LONG COVID-19
Clinical trials for LONG COVID-19 explained in plain language.
Never miss a new study
Get alerted when new LONG COVID-19 trials appear
Sign up with your email to follow new studies for LONG COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can immune therapy IVIG calm long COVID's autonomic storm?
Disease control OngoingThis study tests whether intravenous immunoglobulin (IVIG) can reduce symptoms of autonomic dysfunction—such as dizziness, rapid heartbeat, and fatigue—in people with long COVID. Two hundred participants will receive either IVIG or a placebo (saline) for 9 months, plus coordinate…
Matched conditions: LONG COVID-19
Phase: PHASE2 • Sponsor: Kanecia Obie Zimmerman • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a gut pill ease long COVID? new trial tests larazotide
Disease control OngoingThis Phase 2a study tests whether larazotide, a drug that tightens the gut lining, can reduce long COVID symptoms in people aged 7 to 50. Participants take the drug or a placebo four times daily for 21 days. The goal is to see if it safely improves symptoms like fatigue, brain fo…
Matched conditions: LONG COVID-19
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can tailored rehab help long COVID patients get moving again?
Symptom relief OngoingThis study tests whether a personalized cardiopulmonary rehabilitation program can help people with Long COVID who struggle with exercise intolerance and post-exertional malaise. About 360 participants will do 2-3 supervised sessions per week for 12 weeks, including aerobic exerc…
Matched conditions: LONG COVID-19
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Can magnetic brain stimulation lift Long-COVID brain fog?
Symptom relief OngoingThis small pilot study tests whether repetitive transcranial magnetic stimulation (rTMS) can ease fatigue, brain fog, and other neuropsychiatric symptoms in people with Long-COVID. Ten participants will first receive either active or sham rTMS for 15 sessions, then all will get a…
Matched conditions: LONG COVID-19
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Skin biopsies may reveal long COVID's hidden nerve damage
Knowledge-focused OngoingThis study looks at tiny nerve fibers in the skin of people with Long COVID, POTS, diabetic neuropathy, and those who had COVID-19 without lasting symptoms. By comparing skin samples, researchers hope to find unique patterns that help explain ongoing symptoms like pain and dizzin…
Matched conditions: LONG COVID-19
Sponsor: CND Life Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC